BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  Johnson & Johnson presents new IMAAVY®▼ (nipocalimab) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalised myasthenia gravis

  June 28, 2026

   · 

  20 min read
• Press Releases

  Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis

  June 28, 2026

   · 

  21 min read
• Press Releases

  Siren Biotechnology Awarded $8M in Non-Dilutive Grant Funding from the California Institute for Regenerative Medicine (CIRM) to Support Clinical Development of SRN-101 in High-Grade Glioma

  June 28, 2026

   · 

  3 min read
• Press Releases

  HSS Study Reveals How Early-Life Cellular Process Helps Shape Lifelong Immune Health

  June 28, 2026

   · 

  4 min read
• Press Releases

  Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc

  June 28, 2026

   · 

  5 min read
• Press Releases

  Crescent Biopharma Announces Grants of Inducement Awards - June 26, 2026

  June 28, 2026

   · 

  1 min read
• Press Releases

  Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio

  June 28, 2026

   · 

  5 min read
• Press Releases

  Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease

  June 28, 2026

   · 

  6 min read
• Press Releases

  Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia

  June 28, 2026

   · 

  4 min read
• Press Releases

  Ascendis Joins Multiple Russell U.S. Indexes, Including the Russell 3000®, Russell 1000®, Russell 2500® and Russell Midcap®

  June 28, 2026

   · 

  5 min read